Xinqiao Hospital Of Chongqing

This early-stage trial tested whether specially engineered immune cells could fight a type of head and neck cancer linked to Epstein-Barr virus. Researchers modified patients' own T-cells to recognize and attack cancer cells carrying the virus. The study involved 9 people with ad…

This early-stage trial tested a new cell therapy for head and neck cancers linked to Epstein-Barr virus (EBV). Researchers collected patients' own immune cells (T cells), engineered them to recognize the virus inside cancer cells, and added a component to help them overcome the t…

This early-stage trial tested a new type of cell therapy for cancers caused by HPV, a common virus. Researchers gave patients specially engineered immune cells designed to find and attack cancer cells. The main goal was to find the safest and most effective dose of these cells, t…

This small, early-stage study tested a new type of personalized immune cell therapy called ALPP CAR-T in adults with advanced solid tumors that had stopped responding to standard treatments. The main goals were to see if the treatment was safe and if it could shrink tumors. Resea…

This small, early-stage study tested a new cell therapy for patients with advanced solid tumors that had stopped responding to standard treatments. Doctors collected immune cells from patients, modified them in a lab to target a specific protein (ALPP) found on their tumors, and …